Skip to content
USAID: From The American People TB-DIAH: Tuberculosis Data, Impact Assessment and Communications Hub
  • Knowledge Hub
  • Data Hub
  • Home
  • About
    • Project Overview & Objectives
    • TB DIAH Team
  • Countries
    • Afghanistan
    • Bangladesh
    • Burma
    • Cambodia
    • DRC
    • Ethiopia
    • India
    • Indonesia
    • Kenya
    • Kyrgyz Republic
    • Malawi
    • Mozambique
    • Nigeria
    • Pakistan
    • Philippines
    • South Africa
    • Tajikistan
    • Tanzania
    • Uganda
    • Ukraine
    • Uzbekistan
    • Vietnam
    • Zambia
    • Zimbabwe
  • Tools
    • ARCAssessment of Data Collection, Reporting & Analysis Capacity
    • D2ACData-to-Action Continuum Toolkit
    • MESSAM&E and Surveillance Systems Assessment
    • PBMEFPerformance-Based M&E Framework
    • QTSAQuality of Tuberculosis Services Assessment
    • STEPSurveillance and TB M&E Strengthening Plan
  • Resources
    • Capacity Strengthening
    • Center of Excellence
    • e-Learning Courses
    • NTP Website Activity
    • Resource Library
  • News
    • TB DIAH Digest
    • Social Media
    • 2023 Union Conference
    • Webinars

Resource Tag: XDR-TB

Active TB Drug-Safety Monitoring and Management: Manual for TB Medicines and Regimens

Active TB Drug-Safety Monitoring and Management: Manual for TB Medicines and Regimens
Author(s): National TB Programme Department of Public Health Ministry of Health and Sports The Republic of the Union of Myanmar
Year: 2017
Filed under: Burma, DR-TB, Drug-resistant TB, Guidance and Tools, mdr-tb, Monitoring, NTP, program management, XDR-TB
Continue Reading

Generic programmatic and clinical guide for the introduction of new drugs and shorter regimen for treatment of multi/extensively drug-resistant tuberculosis

Generic programmatic and clinical guide for the introduction of new drugs and shorter regimen for treatment of multi/extensively drug-resistant tuberculosis
Author(s): Challenge TB, KNCV Tuberculosis Foundation
Year: 2017
Filed under: DR-TB, Drug-resistant TB, Guidance and Tools, mdr-tb, multidrug-resistant TB, program management, Treatment, XDR-TB
Continue Reading

Accelerating Action to End TB: Tuberculosis Report to Congress Fiscal Year 2018

Accelerating Action to End TB: Tuberculosis Report to Congress Fiscal Year 2018
Author(s): United States Agency for International Development
Year: 2020
Filed under: Accelerator, Drug-resistant TB, End TB, Governance, Journey to Self-Reliance, mdr-tb, Report, XDR-TB
Continue Reading

National Action Plan for Combating Multidrug-Resistant Tuberculosis

National Action Plan for Combating Multidrug-Resistant Tuberculosis
Author(s): U.S. Government
Year: 2015
Filed under: Accountability, Intervention, Interventions, mdr-tb, multidrug-resistant TB, Plan, strategy, USG, XDR-TB
Continue Reading

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis
Author(s): Trials
Year: 2014
Filed under: Diagnosis, DR-TB, Drug-resistant TB, Journal Article, Rapid tests, Research, XDR-TB
Continue Reading

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Author(s): Clinical Infectious Diseases
Year: 2015
Filed under: Diagnostics, Journal Article, mdr-tb, multidrug-resistant TB, Rapid tests, Research, Treatment, XDR-TB
Continue Reading

Cost analysis of rapid diagnostics for drug-resistant tuberculosis

Cost analysis of rapid diagnostics for drug-resistant tuberculosis
Author(s): BMC Infectious Diseases
Year: 2018
Filed under: Cost, Diagnostics, DR-TB, Drug-resistant TB, Journal Article, Research, Testing, XDR-TB
Continue Reading

Extensively drug-resistant tuberculosis in India: a review

Extensively drug-resistant tuberculosis in India: a review
Author(s): Indian Journal of Medical Research
Year: 2012
Filed under: Drug-resistant TB, India, Journal Article, Prevalence, Research, Review, TB control, XDR-TB
Continue Reading
  • Knowledge Hub
  • Data Hub
TB DIAH Project
University of North Carolina
123 West Franklin Street, Suite 330
Chapel Hill, North Carolina 27516 USA
About
Countries
Topics
Resource Library
News
TB DIAH Digest
Special Features
Assessments
TB Data Hub
Objectives

The TB DIAH project is part of USAID's performance-based measures to end TB—the Global Accelerator to End Tuberculosis. This TB DIAH website features a data hub, guidance, and tools to support the work of the global TB community. TB DIAH makes possible optimal analysis and use of TB data to inform national TB programs, policies, and USAID-supported interventions.

This information was produced with the support of the United States Agency for International Development (USAID) under the terms of the TB Data, Impact Assessment and Communications Hub (TB DIAH) Associate Award No. 7200AA18LA00007. TB DIAH is implemented by the University of North Carolina at Chapel Hill, in partnership with John Snow, Inc. Views expressed are not necessarily those of USAID or the United States government.